Cardioprotection for acute MI in light of the CONDI2/ERIC-PPCI trial: New targets needed

Giblett, Joel P. and Bulluck, Heerajnarain ORCID: (2020) Cardioprotection for acute MI in light of the CONDI2/ERIC-PPCI trial: New targets needed. Interventional Cardiology Review, 15. ISSN 1756-1477

[thumbnail of Published_Version]
PDF (Published_Version) - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (190kB) | Preview


Protection against ischaemia-reperfusion injury after revascularisation in acute myocardial infarction remains an enigma. Many targets have been identified, but after the failure of the recent Effect of Remote Ischaemic Conditioning on Clinical Outcomes in ST-elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention (CONDI2/ERIC-PPCI) trial to show translation to clinical benefit, there is still no pharmacological or mechanical strategy that has translated to clinical practice. This article addresses the results of the CONDI2/ERIC-PPCI trial in the context of previous studies of ischaemic conditioning, and then considers the prospects for other potential targets of cardioprotection. Finally, the authors examine the pitfalls and challenges in trial design for future investigation of cardioprotective strategies. In particular, this article highlights the need for careful endpoint and patient selection, as well as the need to pay attention to the biology of cardioprotection during the study.

Item Type: Article
Uncontrolled Keywords: cardioprotection,cyclosporine a,glucagon-like peptide 1,ischaemia–reperfusion injury,mi,remote ischaemic conditioning,trial design,cardiology and cardiovascular medicine ,/dk/atira/pure/subjectarea/asjc/2700/2705
Faculty \ School:
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 21 Apr 2021 23:49
Last Modified: 23 Oct 2022 02:23
DOI: 10.15420/icr.2020.01


Downloads per month over past year

Actions (login required)

View Item View Item